-
公开(公告)号:US20090233865A1
公开(公告)日:2009-09-17
申请号:US12475482
申请日:2009-05-30
申请人: Hisae Kume , Makoto Yamaguchi , Kenji Mizumoto , Hajime Sasaki
发明人: Hisae Kume , Makoto Yamaguchi , Kenji Mizumoto , Hajime Sasaki
CPC分类号: A61K45/06 , A23C19/076 , A23C21/02 , A23L27/34 , A23L29/231 , A23L29/35 , A23L33/12 , A23L33/15 , A23L33/16 , A23L33/18 , A23L33/19 , A23L33/40 , A23V2002/00 , A61K31/7016 , A61K35/20 , A61K38/1709 , A61K2300/00 , A23V2250/54252 , A23V2250/1842 , A23V2250/18 , A23V2250/5114 , A23V2250/5072 , A23V2250/032 , A23V2250/62 , A23V2250/70 , A23V2250/5424 , A23V2250/156 , A23V2250/1874 , A23V2250/188 , A23V2250/161
摘要: The present inventors discovered that the onset of galactosamine hepatopathy is suppressed by nutritional compositions comprising as essential ingredients: whey protein hydrolysates; lecithin and oils and fats high in oleic acid, which are able to improve the lipid metabolism; and palatinose having an insulin-sparing effect. Furthermore, the whey protein hydrolysate included in the nutritional compositions was found to suppress endotoxin-induced TNF-a and interleukin 6 (IL-6) production in macrophages.
摘要翻译: 本发明人发现半乳糖胺肝病的发作由包含作为必需成分的营养组合物抑制:乳清蛋白水解物; 卵磷脂和高油酸的油脂,能够改善脂质代谢; 和具有胰岛素节约作用的帕拉金糖。 此外,发现包含在营养组合物中的乳清蛋白水解物抑制巨噬细胞中内毒素诱导的TNF-α和白介素6(IL-6)产生。
-
公开(公告)号:US20070172547A1
公开(公告)日:2007-07-26
申请号:US10593550
申请日:2005-03-31
申请人: Hisae Kume , Hajime Sasaki
发明人: Hisae Kume , Hajime Sasaki
IPC分类号: A23C9/12
CPC分类号: A61K35/20 , A23L33/19 , A23L33/40 , A23V2002/00 , A23V2200/3204 , A23V2250/5424 , A23V2250/5114 , A23V2250/5072 , A23V2250/1842 , A23V2250/54242 , A23V2250/022 , A23V2250/032 , A23V2250/034
摘要: The present invention aims at preventing foodborne infections. As a candidate for this purpose, the inventors focused on antibacterial acidic liquid diets, which are acidic due to comprising fermented dairy products as protein source. The antibacterial activity of the acidic liquid diets was compared with the antibacterial activity of a neutral liquid diet and the fermented dairy product used as the basic ingredient. Antibacterial effect of fermented milk such as yogurt is already known. However, the acidic liquid diets unexpectedly exhibited an antibacterial effect higher than the basic ingredient (the fermented dairy product) against Gram-positive bacteria such as MRSA, which are important in terms of public health.
摘要翻译: 本发明旨在防止食源性感染。 作为此目的的候选者,本发明人专注于由于包含发酵乳制品作为蛋白质来源而呈酸性的抗菌酸性液体饮食。 将酸性液体饮食的抗菌活性与中性液体饮食和用作基本成分的发酵乳制品的抗菌活性进行比较。 发酵乳如酸奶的抗菌效果是已知的。 然而,酸性液体饮食意外地显示出比革兰氏阳性细菌如MRSA的基本成分(发酵乳制品)更高的抗菌作用,这在公共卫生方面是重要的。
-
公开(公告)号:US20060073186A1
公开(公告)日:2006-04-06
申请号:US10535585
申请日:2003-11-21
申请人: Hisae Kume , Makoto Yamaguchi , Kenji Mizumoto , Hajime Sasaki
发明人: Hisae Kume , Makoto Yamaguchi , Kenji Mizumoto , Hajime Sasaki
IPC分类号: A61K47/00
CPC分类号: A61K45/06 , A23C19/076 , A23C21/02 , A23L27/34 , A23L29/231 , A23L29/35 , A23L33/12 , A23L33/15 , A23L33/16 , A23L33/18 , A23L33/19 , A23L33/40 , A23V2002/00 , A61K31/7016 , A61K35/20 , A61K38/1709 , A61K2300/00 , A23V2250/54252 , A23V2250/1842 , A23V2250/18 , A23V2250/5114 , A23V2250/5072 , A23V2250/032 , A23V2250/62 , A23V2250/70 , A23V2250/5424 , A23V2250/156 , A23V2250/1874 , A23V2250/188 , A23V2250/161
摘要: The present inventors discovered that the onset of galactosamine hepatopathy is suppressed by nutritional compositions comprising as essential ingredients: whey protein hydrolysates; lecithin and oils and fats high in oleic acid, which are able to improve the lipid metabolism; and palatinose having an insulin-sparing effect. Furthermore, the whey protein hydrolysate included in the nutritional compositions was found to suppress endotoxin-induced TNF-a and interleukin 6 (IL-6) production in macrophages.
摘要翻译: 本发明人发现半乳糖胺肝病的发作由包含作为必需成分的营养组合物抑制:乳清蛋白水解物; 卵磷脂和高油酸的油脂,能够改善脂质代谢; 和具有胰岛素节约作用的帕拉金糖。 此外,发现包含在营养组合物中的乳清蛋白水解物抑制巨噬细胞中内毒素诱导的TNF-α和白介素6(IL-6)产生。
-
公开(公告)号:US20050214282A1
公开(公告)日:2005-09-29
申请号:US10734692
申请日:2003-12-11
IPC分类号: A61B20060101 , A61K39/395 , C07K14/47 , C07K16/24 , C12Q1/68
CPC分类号: C12Q1/6883 , A61K2039/505 , C07K14/47 , C07K16/24 , C12Q2600/158
摘要: The present invention features methods of treating a bone resorption disease or a bone generating disease, methods for prognosing and/or diagnosing a bone resorption disease or a bone generating disease, methods for identifying a compound that modulates bone resorption disease development or bone generating disease development, methods for determining the efficacy of a bone resorption disease therapy or a bone generating disease therapy, and oligonucleotide microarrays containing probes for genes involved in osteoclast development.
摘要翻译: 本发明涉及治疗骨吸收疾病或骨产生疾病的方法,用于预测和/或诊断骨吸收疾病或骨产生疾病的方法,用于鉴定调节骨吸收疾病发展或骨发生疾病发展的化合物的方法 用于确定骨吸收疾病疗法或骨产生疾病疗法的功效的方法和含有涉及破骨细胞发育的基因的探针的寡核苷酸微阵列。
-
公开(公告)号:US20050155909A1
公开(公告)日:2005-07-21
申请号:US10507565
申请日:2002-03-15
申请人: Makoto Inomata , Tsuyoshi Okada , Kozo Imura , Hajime Sasaki
发明人: Makoto Inomata , Tsuyoshi Okada , Kozo Imura , Hajime Sasaki
CPC分类号: C10G45/02 , C10G2300/107
摘要: The present invention is related to a method of subjecting a feed oil to a refining process. This method includes a fractional distillation step 1 in which a feed oil is separated into a distillate oil M1 and a bottom oil M2 by a distillation process, a separation step in which the bottom oil is separated into a bottom light oil and a residue, and a hydrorefining step 3 in which the obtained distillate oil M1 and the bottom oil M2 are subjected to hydrorefining in the presence of hydrogen and a catalyst. In the hydrorefining step 3, the bottom light oil (deasphalted oil M3) is passed through a first catalyst layer 12 of a hydrorefining unit providing a plurality of catalyst layers 12, 13, and 13 filled with a hydrorefining catalyst, and a mixed oil comprising the distillate oil M1 and the bottom light oil (deasphalted oil M3) is passed through a downstream catalyst layer 13 and subject to a hydrogenation process.
摘要翻译: 本发明涉及一种使进料油进行精炼处理的方法。 该方法包括分馏步骤1,其中通过蒸馏方法将原料油分离成馏出油M 1和底部油M 2;分离步骤,其中将底部油分离成底部轻油和残余物 和加氢精制步骤3,其中所得馏出油M 1和底部油M 2在氢气和催化剂存在下进行加氢精制。 在加氢精制工序3中,使底部轻油(脱沥青油M 3)通过加氢精制机的第一催化剂层12,该催化剂层提供填充有加氢精制催化剂的多个催化剂层12,13,13,混合油 包括馏出油M 1和底部轻油(脱沥青油M 3)通过下游催化剂层13并经受氢化处理。
-
公开(公告)号:US08778404B2
公开(公告)日:2014-07-15
申请号:US12475482
申请日:2009-05-30
申请人: Hisae Kume , Makoto Yamaguchi , Kenji Mizumoto , Hajime Sasaki
发明人: Hisae Kume , Makoto Yamaguchi , Kenji Mizumoto , Hajime Sasaki
IPC分类号: A61K35/20
CPC分类号: A61K45/06 , A23C19/076 , A23C21/02 , A23L27/34 , A23L29/231 , A23L29/35 , A23L33/12 , A23L33/15 , A23L33/16 , A23L33/18 , A23L33/19 , A23L33/40 , A23V2002/00 , A61K31/7016 , A61K35/20 , A61K38/1709 , A61K2300/00 , A23V2250/54252 , A23V2250/1842 , A23V2250/18 , A23V2250/5114 , A23V2250/5072 , A23V2250/032 , A23V2250/62 , A23V2250/70 , A23V2250/5424 , A23V2250/156 , A23V2250/1874 , A23V2250/188 , A23V2250/161
摘要: The present inventors discovered that the onset of galactosamine hepatopathy is suppressed by nutritional compositions comprising as essential ingredients: whey protein hydrolysates; lecithin and oils and fats high in oleic acid, which are able to improve the lipid metabolism; and palatinose having an insulin-sparing effect. Furthermore, the whey protein hydrolysate included in the nutritional compositions was found to suppress endotoxin-induced TNF-a and interleukin 6 (IL-6) production in macrophages.
摘要翻译: 本发明人发现半乳糖胺肝病的发作由包含作为必需成分的营养组合物抑制:乳清蛋白水解物; 卵磷脂和高油酸的油脂,能够改善脂质代谢; 和具有胰岛素节约作用的帕拉金糖。 此外,发现包含在营养组合物中的乳清蛋白水解物抑制巨噬细胞中内毒素诱导的TNF-α和白介素6(IL-6)产生。
-
37.
公开(公告)号:US20130103417A1
公开(公告)日:2013-04-25
申请号:US13807259
申请日:2011-06-24
申请人: Kumiko Seto , Kikuo Umegaki , Masayuki Ohta , Shuntaro Yui , Satoshi Mitsuyama , Kazuki Matsuzaki , Hajime Sasaki , Takuya Kamiyama , Hisaaki Ochi , Yoshihiko Nagamine , Yuji Oka
发明人: Kumiko Seto , Kikuo Umegaki , Masayuki Ohta , Shuntaro Yui , Satoshi Mitsuyama , Kazuki Matsuzaki , Hajime Sasaki , Takuya Kamiyama , Hisaaki Ochi , Yoshihiko Nagamine , Yuji Oka
IPC分类号: G06Q50/22
CPC分类号: G06Q50/22 , G06Q10/06316 , G06Q10/103
摘要: Provided is a medical care support system for the sharing and reusing of medical information on the basis of a workflow which is a flow of medical-related services. A workflow step that was executed prior to an ongoing workflow step is selected by using a medical information database which has registered a workflow and information of each workflow step in association with medical information; and information is inputted by medical staff in the ongoing workflow step while the medical information registered in the selected workflow step being referred to; and the medical information being referred to and the inputted information are registered in the medical information database in association with the ongoing workflow step.
摘要翻译: 提供了一种医疗保健系统,用于基于作为医疗相关服务流程的工作流程来共享和再利用医疗信息。 通过使用已经注册了工作流的医疗信息数据库和与医疗信息相关联的每个工作流步骤的信息来选择在正在进行的工作流程步骤之前执行的工作流步骤; 并且在正在进行的工作流程步骤中由医务人员输入信息,同时参考在所选择的工作流步骤中登记的医疗信息; 并且与所进行的工作流步骤相关联地将所引用的医疗信息和输入的信息登记在医疗信息数据库中。
-
公开(公告)号:US20120287131A1
公开(公告)日:2012-11-15
申请号:US13515557
申请日:2010-12-16
CPC分类号: A61B8/5238 , A61B6/025 , A61B6/463 , A61B6/5241 , A61B6/5247 , G06T3/0068 , G06T7/30 , G06T2207/10072 , G06T2207/10136 , G06T2207/30004
摘要: In the process of a registration between first and second images captured by different image pickup apparatuses, even if corresponding parts have different pixel values, different shapes and different field of view, the registration can be carried out with high speed and high degree of precision. In order to perform the registration between the first and second images, either of the first and second images is divided into segmented regions, and given physical property values are set to the segmented regions. Further, an image (pseudo image) having similar pixel values, shapes and field of view to the other image is created, and the pseudo image and the second image that have the same features are positioned, thereby performing the registration between the first and second images.
摘要翻译: 在由不同的图像拾取装置拍摄的第一和第二图像之间的对准过程中,即使相应的部分具有不同的像素值,不同的形状和不同的视野,可以以高速度和高精度执行配准。 为了执行第一和第二图像之间的对准,将第一和第二图像中的任一个划分成分割区域,并且给定的物理属性值被设置到分割区域。 此外,创建具有与另一图像相似的像素值,形状和视场的图像(伪图像),并且具有相同特征的伪图像和第二图像被定位,从而执行第一和第二图像之间的对准 图片。
-
公开(公告)号:USD565433S1
公开(公告)日:2008-04-01
申请号:US29283069
申请日:2007-08-06
申请人: Michel Ratajski , Susumu Shibata , Hajime Sasaki , Yoichi Yaguci
设计人: Michel Ratajski , Susumu Shibata , Hajime Sasaki , Yoichi Yaguci
-
公开(公告)号:US20060110998A1
公开(公告)日:2006-05-25
申请号:US10531325
申请日:2003-10-15
CPC分类号: H05K9/009 , Y10T442/2418 , Y10T442/2926 , Y10T442/654 , Y10T442/655 , Y10T442/699
摘要: A conductive cushion material that can effectively shield electromagnetic wave leaking from a housing of an information device such as a cellular phone and also has a cushioning function to protect electronics parts comparatively fragile to impact, as well as a method for manufacturing the same, where manufacturing processes are simple and easy, are provided. More specifically, a conductive cushion material comprising a fiber aggregate (A) composed of conductive fine wires and an elastic resin (B) containing a conductive filler (C), characterized in that at least a part of edges of the fiber aggregate (A) is exposed out of the external surface of the cushion material, while the rest of the edges are embedded in the cushion material, and that the elastic resin (B) has many cavities therein, while uniformly mixed with the conductive filler (C), and a method for manufacturing the same are provided.
摘要翻译: 导电性缓冲材料,其能够有效地屏蔽从诸如蜂窝式电话的信息装置的壳体中泄漏的电磁波,并且还具有缓冲功能,以保护电子部件比较脆弱地影响,以及其制造方法,其中制造 流程简单易行。 更具体地说,包括由导电细线构成的纤维聚集体(A)和含有导电填料(C)的弹性树脂(B)的导电性缓冲材料,其特征在于,所述纤维聚集体(A)的至少一部分边缘, 露出了缓冲材料的外表面,而其余边缘嵌入缓冲材料中,并且弹性树脂(B)在其中具有许多空腔,同时与导电填料(C)均匀混合,以及 提供了其制造方法。
-
-
-
-
-
-
-
-
-